Closing the Funding Gap: Sweden–UK Life Sciences Investor Breakfast

17 November, 09:00 - 11:00

Scientific innovation should not be stalled due to missing capital. Yet too often, Swedish life sciences companies hit a wall on the road to scale: the funding gap between early-stage investment and later-stage growth. 



This Sweden-UK Investor Breakfast aims to bridge that gap, bringing ambitious Swedish bio companies into the same room as the investors with the capital they need and the conviction to back them. The UK is one of the world's deepest pools of life science capital, and Sweden is one of its most productive sources of innovation.


Hosted by the Embassy of Sweden in London, this is an intimate, purposeful morning built for valuable connections over broad networking. Expect focused conversation, the right people, and real momentum towards capital.


Three reasons for you to lean in:


  •   Connect directly with UK investors actively looking at life science opportunities


  •   Position your company in front of the capital you need to scale in the UK and beyond


  •   Gain insights into what British investors want to see – and how to give it to them


If you're building something in life sciences and ready to grow, this is your room.

Location

Alströmer, Embassy of Sweden London

5 Upper Montagu St., London, United Kingdom

Delegate

The Swedish Chamber of Commerce

Jan Ståhlberg

Founder & Managing Partner

Trill Impact

The Swedish Chamber of Commerce

Emmie Jones

Partner

White & Case

The Swedish Chamber of Commerce

David Samuelson

Partner

Nordic Capital